The University of Chicago Header Logo

Connection

Richard Larson to Pyridazines

Back to Details
This is a "connection" page, showing publications Richard Larson has written about Pyridazines.
Richard Larson
Connection Strength
0.108
Pyridazines
  1. BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia. Cancer Cell. 2014 Sep 08; 26(3):428-442.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.